Market Access How the hyperlocal delivery model could empower pharmacists ... The NHS is currently facing significant challenges, including staff shortages, union strikes, supply chain issues, and increasing patient volume.
Market Access 12 questions with: Daniel Kohlstaedt Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023
Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.
Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.
Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years.
News Daiichi and AZ pull Dato-DXd filing in Europe too AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.